Cancer vaccines and carbohydrate epitopes
- PMID: 21964054
- PMCID: PMC3208265
- DOI: 10.1016/j.vaccine.2011.09.009
Cancer vaccines and carbohydrate epitopes
Abstract
Tumor-associated carbohydrate antigens (TACA) result from the aberrant glycosylation that is seen with transformation to a tumor cell. The carbohydrate antigens that have been found to be tumor-associated include the mucin related Tn, Sialyl Tn, and Thomsen-Friedenreich antigens, the blood group Lewis related Lewis(Y), Sialyl Lewis(X) and Sialyl Lewis(A), and Lewis(X) (also known as stage-specific embryonic antigen-1, SSEA-1), the glycosphingolipids Globo H and stage-specific embryonic antigen-3 (SSEA-3), the sialic acid containing glycosphingolipids, the gangliosides GD2, GD3, GM2, fucosyl GM1, and Neu5GcGM3, and polysialic acid. Recent developments have furthered our understanding of the T-independent type II response that is seen in response to carbohydrate antigens. The selection of a vaccine target antigen is based on not only the presence of the antigen in a variety of tumor tissues but also on the role this antigen plays in tumor growth and metastasis. These roles for TACAs are being elucidated. Newly acquired knowledge in understanding the T-independent immune response and in understanding the key roles that carbohydrates play in metastasis are being applied in attempts to develop an effective vaccine response to TACAs. The role of each of the above mentioned carbohydrate antigens in cancer growth and metastasis and vaccine attempts using these antigens will be described.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Figures



Similar articles
-
Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines.Adv Exp Med Biol. 2001;491:369-402. doi: 10.1007/978-1-4615-1267-7_24. Adv Exp Med Biol. 2001. PMID: 14533809 Review.
-
Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives.Cancers (Basel). 2022 Jan 27;14(3):645. doi: 10.3390/cancers14030645. Cancers (Basel). 2022. PMID: 35158915 Free PMC article. Review.
-
Valency and density matter: Deciphering impacts of immunogen structures on immune responses against a tumor associated carbohydrate antigen using synthetic glycopolymers.Biomaterials. 2016 Sep;101:189-98. doi: 10.1016/j.biomaterials.2016.05.050. Epub 2016 Jun 2. Biomaterials. 2016. PMID: 27294537 Free PMC article.
-
Carbohydrate antigens as targets for active specific immunotherapy.Cancer Immunol Immunother. 1996 Nov;43(3):152-7. doi: 10.1007/s002620050316. Cancer Immunol Immunother. 1996. PMID: 9001568 Review.
-
Selection of GM2, fucosyl GM1, globo H and polysialic acid as targets on small cell lung cancers for antibody mediated immunotherapy.Cancer Immunol Immunother. 2005 Oct;54(10):1018-25. doi: 10.1007/s00262-005-0663-8. Epub 2005 May 31. Cancer Immunol Immunother. 2005. PMID: 15926079 Free PMC article.
Cited by
-
The cancer glycocode as a family of diagnostic biomarkers, exemplified by tumor-associated gangliosides.Front Oncol. 2023 Oct 26;13:1261090. doi: 10.3389/fonc.2023.1261090. eCollection 2023. Front Oncol. 2023. PMID: 37954075 Free PMC article. Review.
-
The human IgG anti-carbohydrate repertoire exhibits a universal architecture and contains specificity for microbial attachment sites.Sci Transl Med. 2015 Jan 7;7(269):269ra1. doi: 10.1126/scitranslmed.3010524. Sci Transl Med. 2015. PMID: 25568069 Free PMC article.
-
MEDULLARY THYROID CANCER THAT STAINS NEGATIVE FOR CA 19-9 HAS DECREASED METASTATIC POTENTIAL.Endocr Pract. 2015 Jun;21(6):590-4. doi: 10.4158/EP14357.OR. Epub 2015 Feb 25. Endocr Pract. 2015. PMID: 25716629 Free PMC article.
-
Anti-glycan IgM repertoires in newborn human cord blood.PLoS One. 2019 Jul 31;14(7):e0218575. doi: 10.1371/journal.pone.0218575. eCollection 2019. PLoS One. 2019. PMID: 31365539 Free PMC article.
-
Fucosylated Antigens in Cancer: An Alliance toward Tumor Progression, Metastasis, and Resistance to Chemotherapy.Front Oncol. 2018 Feb 23;8:39. doi: 10.3389/fonc.2018.00039. eCollection 2018. Front Oncol. 2018. PMID: 29527514 Free PMC article. Review.
References
-
- Davis ID, Jefford M, Parente P, Cebon J. Rational approaches to human cancer immunotherapy. Journal of Leukocyte Biology. 2003;73:3–29. - PubMed
-
- Coley WB. The treatment of malignant tumors by repeated inoculations of erysipelas: with a report of ten original cases. Am J Med Sci. 1893;105:487–511. - PubMed
-
- Starnes CO. Coley’s toxins in perspective. Nature. 1992;357:11–12. - PubMed
-
- The University of Texas MD Anderson Cancer Center Coley Toxins Detailed Scientific Review. [Accessed 5/8/11]; http://www.mdanderson.org/education-and-research/resources-for-professio....
-
- Silverstein AM. Chapter 11 Transplantation and Immunogenetics. In: Silverstein AM, editor. A History of Immunology. New York: Elsevier Academic Press; 2009.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources